During Q4, the company billed 11,789 tissue-based units and 12,036 liquid-based units, representing growth of 50% and 10%, respectively.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.